The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
As Alzheimer’s cases grow, scientists have been deep in debate over its causes. Now, with treatments are on the horizon, the new race is to ready the health system.
The symptoms of menopause, which can include sleep disturbance, depression, anxiety and “brain fog”, can span perimenopause and last for up to 10 years.
Although a great deal of research is still required, it may one day be possible to identify and treat people suffering from CTE, or at risk of it.
Research into snake venom pivoted from Alzheimer's disease to COVID-19 when the coronavirus reared its head.
Depression is one of several mental health conditions being successfully treated by transcranial magnetic stimulation.
Over coming decades, Australia’s economic prosperity and wellbeing will depend more and more on our ability to foster and sustain a culture of innovation. Universities will be vital to this endeavour, not only in their role as centres for...
Dummy text
